West Pharmaceutical Services (WST) Restructuring Costs (2009 - 2013)

West Pharmaceutical Services has disclosed Restructuring Costs across 5 years of filings, most recently posting $100000.0 for Q3 2013.

• Restructuring Costs for Q3 2013 came in at $100000.0, down 95.45% year-over-year; the trailing twelve-month figure through Dec 2013 was -$500000.0 (down 138.46% YoY), and the FY2013 annual result was -$500000.0, down 138.46% from the prior year.
• Restructuring Costs came in at $100000.0 for Q3 2013 at West Pharmaceutical Services, up from -$800000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $14.7 million in Q4 2010 to a low of -$3.6 million in Q3 2009.
• The 5-year median for Restructuring Costs is $850000.0 (2010), against an average of $1.9 million.
• Across the five-year window, Restructuring Costs soared 500.0% in 2010 and plunged 260.0% in 2013, its largest moves.
• West Pharmaceutical Services' Restructuring Costs stood at $11.0 million in 2009, then soared by 33.64% to $14.7 million in 2010, then tumbled by 81.63% to $2.7 million in 2011, then tumbled by 144.44% to -$1.2 million in 2012, then surged by 108.33% to $100000.0 in 2013.
• The last three Restructuring Costs figures came in at $100000.0 (Q3 2013), -$800000.0 (Q2 2013), and $200000.0 (Q1 2013), per Business Quant data.